Showing 561-570 of 6662 results for "".
Letter to the Editor
https://practicaldermatology.com/topics/atopic-dermatitis/letter-to-the-editor-1/23091/Letter to the Editor: Dermatologists Must Focus on Safety; Understand Device Clearances
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/letter-to-the-editor/23072/Physician Spotlight: Lynn McKinley-Grant, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-1/22990/Dear Doctor: Here's Why I'm a Long-term Employee
https://practicaldermatology.com/topics/practice-management/dear-doctor-heres-why-im-a-long-term-employee/22068/What makes employees happy and prevents turnover in practice.Unpacking the Latest CMS Proposal
https://practicaldermatology.com/topics/practice-management/unpacking-the-latest-cms-proposal/20349/What might these changes mean for dermatologists?Inflammatory Responses: Managing Psoriasis in Light of Comorbidities
https://practicaldermatology.com/topics/psoriasis/inflammatory-responses-managing-psoriasis-in-light-of-comorbidities/20440/The accumulated evidence suggests that dermatologists must take an active role in addressing risks.Lessons from HBO's Docuseries The Defiant Ones
https://practicaldermatology.com/topics/practice-management/lessons-from-hbos-docuseries-emthe-defiant-onesem/20606/How Dr. Dre and Jimmy Iovine disrupted an industry and made billions.Letters to the Editor
https://practicaldermatology.com/topics/practice-management/letters-to-the-editor/20595/How To (and How Not To) Build Your Email List
https://practicaldermatology.com/topics/practice-management/how-to-and-how-not-to-build-your-email-list/20636/In an era when we are all inundated with excess email, how can you convince people to subscribe to your newsletter and announcements?A Non-Invasive 2-Gene Molecular Assay Shows Promise in Assessment of Pigmented Lesions
https://practicaldermatology.com/topics/skin-cancer-photoprotection/a-non-invasive-2-gene-molecular-assay-shows-promise-in-assessment-of-pigmented-lesions/20705/More studies are needed, but a non-invasive assay that identified melanoma gene expression could support clinical decision making.